United States (US) Genomic Medicine Market (2025-2031) | Analysis, Industry, Value, Share, Forecast, Competitive Landscape, Growth, Size & Revenue, Outlook, Trends, Segmentation, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Genomic Medicine Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Genomic Medicine Market - Industry Life Cycle

3.4 United States (US) Genomic Medicine Market - Porter's Five Forces

3.5 United States (US) Genomic Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United States (US) Genomic Medicine Market Revenues & Volume Share, By End- User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders and chronic diseases driving the demand for personalized medicine solutions.

4.2.2 Technological advancements in genomics leading to the development of innovative diagnostic tools and therapies.

4.2.3 Supportive government initiatives and funding for genomic research and precision medicine initiatives.

4.3 Market Restraints

4.3.1 High costs associated with genomic testing and personalized medicine limiting adoption rates.

4.3.2 Privacy and data security concerns related to genomic data hindering patient acceptance.

4.3.3 Limited availability of skilled professionals and infrastructure for genomic testing and analysis.

6.1 United States (US) Genomic Medicine Market, By Application

6.1.1 Overview and Analysis

6.1.2 United States (US) Genomic Medicine Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United States (US) Genomic Medicine Market Revenues & Volume, By Oncology, 2021- 2031F

6.1.4 United States (US) Genomic Medicine Market Revenues & Volume, By Cardiology, 2021- 2031F

6.1.5 United States (US) Genomic Medicine Market Revenues & Volume, By Paediatrics, 2021- 2031F

6.1.6 United States (US) Genomic Medicine Market Revenues & Volume, By Endocrinology, 2021- 2031F

6.1.7 United States (US) Genomic Medicine Market Revenues & Volume, By Respiratory Medicine, 2021- 2031F

6.1.8 United States (US) Genomic Medicine Market Revenues & Volume, By Rare Genetic Disorders, 2021- 2031F

6.1.9 United States (US) Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F

6.1.10 United States (US) Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Genomic Medicine Market, By End- User

6.2.1 Overview and Analysis

6.2.2 United States (US) Genomic Medicine Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 United States (US) Genomic Medicine Market Revenues & Volume, By Clinics, 2021- 2031F

6.2.4 United States (US) Genomic Medicine Market Revenues & Volume, By Academic Institutions, 2021- 2031F

6.2.5 United States (US) Genomic Medicine Market Revenues & Volume, By Research Institutions, 2021- 2031F

7.1 United States (US) Genomic Medicine Market Export to Major Countries

7.2 United States (US) Genomic Medicine Market Imports from Major Countries

8.1 Number of FDA approvals for genomic medicine products.

8.2 Growth in research and development (RD) investments in genomic medicine.

8.3 Adoption rates of genomic testing and personalized medicine solutions.

8.4 Number of partnerships and collaborations in the genomic medicine sector.

8.5 Patient satisfaction and engagement levels with genomic medicine services.

9.1 United States (US) Genomic Medicine Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United States (US) Genomic Medicine Market Opportunity Assessment, By End- User, 2021 & 2031F

10.1 United States (US) Genomic Medicine Market Revenue Share, By Companies, 2024

10.2 United States (US) Genomic Medicine Market Competitive Benchmarking, By Operating and Technical Parameters